141 related articles for article (PubMed ID: 4364937)
21. Susceptibility of herpesviruses to three nucleoside analogues and their combinations and enhancement of the antiviral effect of acid pH.
Fiala M; Chow AW; Miyasaki K; Guze LB
J Infect Dis; 1974 Jan; 129(1):82-5. PubMed ID: 4358268
[No Abstract] [Full Text] [Related]
22. In vitro and in vivo resistance of herpes simplex virus to 9-(2-hydroxyethoxymethyl)guanine (acycloguanosine).
Smith KO; Kennell WL; Poirier RH; Lynd FT
Antimicrob Agents Chemother; 1980 Feb; 17(2):144-50. PubMed ID: 6247967
[TBL] [Abstract][Full Text] [Related]
23. Methods for screening and profiling inhibitors of herpes simplex viruses.
Gong EY
Methods Mol Biol; 2013; 1030():303-13. PubMed ID: 23821277
[TBL] [Abstract][Full Text] [Related]
24. The effect of cytosine arabinoside on the replication of herpes simplex virus.
Levitt J; Becker Y
Virology; 1967 Jan; 31(1):129-34. PubMed ID: 4289345
[No Abstract] [Full Text] [Related]
25. The effect of cytosine arabinoside on virus production in various cells infected with herpes simplex virus types 1 and 2.
Nutter RL; Rapp F
Cancer Res; 1973 Jan; 33(1):166-70. PubMed ID: 4345149
[No Abstract] [Full Text] [Related]
26. Pathological findings of adenine arabinoside (ARA-A) and cytarabine (ARA-C) in the treatment of herpes simplex encephalitis in rabbit model.
Narang HK
Antiviral Res; 1982 May; 2(1-2):53-67. PubMed ID: 6285819
[TBL] [Abstract][Full Text] [Related]
27. Susceptibility to acyclovir of herpes simplex virus isolates obtained between 1977 and 1996 in Japan.
Hasegawa T; Kawana T; Okuda T; Horii M; Tsukada T; Shiraki K
J Med Virol; 2001 Jan; 63(1):57-63. PubMed ID: 11130888
[TBL] [Abstract][Full Text] [Related]
28. Rapid method for determining the susceptibility of herpes simplex virus to acyclovir.
Howell CL; Miller MJ
Diagn Microbiol Infect Dis; 1984 Apr; 2(2):77-84. PubMed ID: 6325082
[TBL] [Abstract][Full Text] [Related]
29. Antiviral susceptibility of Herpes simplex viruses and its clinical correlates: a single center's experience.
Rabella N; Otegui M; Labeaga R; Rodríguez P; Margall N; Gurguí M; Prats G
Clin Infect Dis; 2002 Apr; 34(8):1055-60. PubMed ID: 11914993
[TBL] [Abstract][Full Text] [Related]
30. Effect of cytosine arabinoside on viral-specific protein synthesis in cells infected with herpes simplex virus.
Ward RL; Stevens JG
J Virol; 1975 Jan; 15(1):71-80. PubMed ID: 46282
[TBL] [Abstract][Full Text] [Related]
31. Enhanced survival of ultraviolet-irradiated herpes simplex virus in cells exposed to antiviral agents.
Schnipper LE; Lewin AA; Crumpacker CS
Mutat Res; 1983 Feb; 116(2):65-72. PubMed ID: 6298618
[TBL] [Abstract][Full Text] [Related]
32. Profiling penciclovir susceptibility and prevalence of resistance of herpes simplex virus isolates across eleven clinical trials.
Sarisky RT; Bacon TH; Boon RJ; Duffy KE; Esser KM; Leary J; Locke LA; Nguyen TT; Quail MR; Saltzman R
Arch Virol; 2003 Sep; 148(9):1757-69. PubMed ID: 14505088
[TBL] [Abstract][Full Text] [Related]
33. More rapid isolation of herpes simplex virus in a continuous line of mink lung cells than in Vero or human fibroblast cells.
Salmon VC; Stanberry LR; Overall JC
Diagn Microbiol Infect Dis; 1984 Sep; 2(4):317-24. PubMed ID: 6091988
[TBL] [Abstract][Full Text] [Related]
34. Activities of 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-iodocytosine and its metabolites against herpes simplex virus types 1 and 2 in cell culture and in mice infected intracerebrally with herpes simplex virus type 2.
Schinazi RF; Fox JJ; Watanabe KA; Nahmias AJ
Antimicrob Agents Chemother; 1986 Jan; 29(1):77-84. PubMed ID: 3015003
[TBL] [Abstract][Full Text] [Related]
35. Nucleic acids. 3. Antiviral activity of nucleotides and dinucleoside phosphates containing ara-cytidine.
Renis HE; Hollowell CA; Underwood GE
J Med Chem; 1967 Sep; 10(5):777-82. PubMed ID: 4292736
[No Abstract] [Full Text] [Related]
36. Involvement of microtubules in cytopathic effects of animal viruses: early proteins of adenovirus and herpesvirus inhibit formation of microtubular paracrystals in HeLa-S3 cells.
Ebina T; Satake M; Ishida N
J Gen Virol; 1978 Mar; 38(3):535-48. PubMed ID: 204735
[TBL] [Abstract][Full Text] [Related]
37. Prolongation of herpes simplex virus latency in cultured human cells by temperature elevation.
O'Neill FJ
J Virol; 1977 Oct; 24(1):41-6. PubMed ID: 198583
[TBL] [Abstract][Full Text] [Related]
38. Development of herpes simplex virus disease in patients who are receiving cidofovir.
Wyles DL; Patel A; Madinger N; Bessesen M; Krause PR; Weinberg A
Clin Infect Dis; 2005 Sep; 41(5):676-80. PubMed ID: 16080090
[TBL] [Abstract][Full Text] [Related]
39. Antiherpesvirus activity of 9-(4-hydroxy-3-hydroxy-methylbut-1-yl)guanine (BRL 39123) in cell culture.
Boyd MR; Bacon TH; Sutton D; Cole M
Antimicrob Agents Chemother; 1987 Aug; 31(8):1238-42. PubMed ID: 3631945
[TBL] [Abstract][Full Text] [Related]
40. Production of tubular structures in Vero cells infected with herpes simplex virus type 2; effects of ultraviolet light irradiation and antimetabolites.
Iwasaka T; Oda H; Mori R; Miyazono J; Nagafuchi S
J Gen Virol; 1979 Jul; 44(1):57-67. PubMed ID: 228001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
